We use cookies to improve your experience. By your continued use of this site you accept such use. To change your settings please see our Privacy Policy.
I accept

12 Jul. 2022

OEP granted an exclusive right to distribute and commercialize new drug for DLBCL in Taiwan and Singapore

OEP granted an exclusive right to distribute and commercialize new drug for DLBCL in Taiwan and Singapore_Economic Daily News

 

Back
OEP

： +886-2-27554881

： oep@oepgroup.com

13F., No. 128, Sec. 6, Chengde Rd.,
Taipei 112, Taiwan, R.O.C.

Terms of Use | Privacy Policy

Copyright ©2024. Orient EuroPharma Co., Ltd. All rights reserved.